EI
PRAH

EAM Investors’s PRA Health Sciences, Inc. PRAH Stock Holding History

EAM Investors’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-14,180
Closed -$1.3M – 351
2018
Q4 		$1.3M Buy
+14,180
New +$1.43M 0.35% 133
2018
Q2 		– Sell
-22,071
Closed -$1.83M – 385
2018
Q1 		$1.83M Buy
22,071
+1,696
+8% +$151K 0.3% 145
2017
Q4 		$1.86M Sell
20,375
-11,257
-36% -$936K 0.33% 141
2017
Q3 		$2.41M Sell
31,632
-9,528
-23% -$720K 0.32% 129
2017
Q2 		$3.09M Sell
41,160
-2,952
-7% -$205K 0.51% 66
2017
Q1 		$2.88M Buy
+44,112
New +$2.6M 0.45% 100
2016
Q4 		– Sell
-58,398
Closed -$3.3M – 396
2016
Q3 		$3.3M Buy
+58,398
New +$2.86M 0.44% 64

Other funds holding PRAH

KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

EAM Investors's PRAH Position: Q1 2019 in Review

EAM Investors sold out of PRA Health Sciences, Inc. (PRAH) in Q1 2019, closing a stake of 14,180 shares — an estimated $1.3M sold.

EAM Investors first reported a position in PRAH in Q3 2016 and held it in 7 quarters. The position peaked at $3.3M in Q3 2016. 354 funds tracked by Wall St. Rank hold PRAH as of Q1 2019.

  • EAM Investors reported no remaining PRA Health Sciences, Inc. position as of Q1 2019 after selling out during the quarter.
  • EAM Investors sold 14,180 PRA Health Sciences, Inc. shares in Q1 2019, an estimated $1.3M.
  • EAM Investors first reported a position in PRA Health Sciences, Inc. in Q3 2016 and held it in 7 quarters.
  • EAM Investors's PRA Health Sciences, Inc. position peaked at $3.3M in Q3 2016.
  • 354 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q1 2019.

Based on EAM Investors's 13F filing for Q1 2019, filed 13 May 2019.